# Top 50 Life Science Startup Investors in May 2026

## ARCH Venture Partners
- Type: VC Fund
- Location: Chicago, Illinois, United States
- Relevant deals: 23
- Stages: Series A, Series B, Series C
- Focus: Biotechnology, Health Care, Therapeutics

ARCH Venture Partners provides seed / early stage venture capital for technology firms in information technology, life sciences, and physical sciences

## Sofinnova Partners
- Type: VC Fund
- Location: Paris, Ile-de-France, France
- Relevant deals: 21
- Stages: Series A, Series B, Series C
- Focus: Biotechnology, Health Care, Medical

Sofinnova Partners is a leading European venture capital firm in life sciences, specializing in healthcare and sustainability. Based in Paris, London and Milan, the firm brings together a team of professionals from all over the world with strong scientific, medical and business expertise.

## Northpond Ventures
- Type: VC Fund
- Location: Bethesda, Maryland, United States
- Relevant deals: 20
- Stages: Series A, Series B, Series C
- Focus: Biotechnology, Health Care, Life Science

Northpond Ventures is a science-driven venture capital firm headquartered in Bethesda, Maryland. Our mission is to build a better tomorrow. Our investments are focused on life sciences, technology, and affiliated industries.

## Alexandria Venture Investments
- Type: VC Fund
- Location: Pasadena, California, United States
- Relevant deals: 19
- Stages: Series A, Series B, Series C
- Focus: Biotechnology, Health Care, Therapeutics

Alexandria Venture Investments is a venture capital firm that develops work in real estate technology, and healthcare sectors. The company's strategic venture capital platform is Alexandria Venture Investments. Since its inception in 1996, the company has invested in disruptive life science, agrifood tech, and technology companies that aredeveloping transformative new modalities and platforms to meaningfully improve human health.

## Parkwalk Advisors
- Type: VC Fund
- Location: London, England, United Kingdom
- Relevant deals: 17
- Stages: Seed, Series A, Series B
- Focus: Biotechnology, Health Care, Software

Parkwalk is a London-based fund management firm. Parkwalk invests in UK technology companies that have IP backing and freedom to operate, generally spun out of UK universities. Their funds seek to generate capital gains for their investors, enhanced by the attractive tax relief provided by EIS. Parkwalk entered this investment sector in 2009,anticipating a wave of tax-efficient incentives launched by the UK Government to stimulate innovative emerging technology companies and thereby help drive economic growth.Parkwalk utilises academic, technology transfer, venture capital and personal networks developed over many years to gain access to the highest calibre deal-flow. In 2017 Parkwalk joined forces with IP Group plc, a leading intellectual property commercialisation company that is listed on the Main Market of the London Stock Exchange under the ticker symbol IPO. As at March 2019 the combined group has net assets of £1.2bn.

## Novartis Venture Fund
- Type: VC Fund
- Location: Basel, Basel-Stadt, Switzerland
- Relevant deals: 17
- Stages: Series B, Series A, Series C
- Focus: Biotechnology, Health Care, Therapeutics

Our primary focus is on the development of novel therapeutics and platforms. We balance the therapeutic focus with investments in medical devices, diagnostics or drug delivery systems. In our investments we look for unmet need and clinical impact, novel proprietary science and understanding of mechanism, management and board experience and capitalefficiency in the program.We prefer to have our initial investment at the early stage to build the company and follow with additional investment in pace with the company:tm:s progress. We continue our approach of larger focused investments and anticipate total investments up to USD 30 to 50 mio per company over its life, but it can be as little as 100'000 USD to get started. We will increase our activities to lead or co-lead deals further and remain open to participate in larger syndicates. SectorsNew therapeutics & platformsMedical devices/implantsDiagnostics/biomarkersDrug delivery/biopolymersGeographyUSA/CanadaEuropeSwitzerlandAsia/Pacific

## OrbiMed
- Type: VC Fund
- Location: New York, New York, United States
- Relevant deals: 15
- Stages: Series B, Series A, Series C
- Focus: Biotechnology, Health Care, Pharmaceutical

Leading Global Healthcare Platform with Deep Proprietary Resources and Global Industry Coverage.

## Fifty Years
- Type: VC Fund
- Location: San Francisco, California, United States
- Relevant deals: 15
- Stages: Seed, Series A, Series B
- Focus: Biotechnology, Health Care, Medical

WE BACK HEROES   using technology to solve the world's biggest problems

## SR One
- Type: VC Fund
- Location: Cambridge, Massachusetts, United States
- Relevant deals: 13
- Stages: Series A, Series B, Series C
- Focus: Biotechnology, Health Care, Therapeutics

SR One Capital Management is a leading trans-Atlantic biotech venture capital firm that partners with top entrepreneurs, scientists and investment partners to seek to build elite biotechnology companies. Our mission is to translate ground-breaking technologies into next generation medicines to benef

## Oxford Science Enterprises
- Type: VC Fund
- Location: Oxford, Oxfordshire, United Kingdom
- Relevant deals: 13
- Stages: Seed, Series A
- Focus: Biotechnology, Health Care, Software

Oxford Sciences Innovation is the world’s largest university-partnered venture firm. We work with the University of Oxford to build companies that create fundamental technologies: science-based businesses capable of tackling the planet’s toughest problems. We invest in life science, AI and software, healthcare, and deep tech to create companiestaking on challenges like nuclear fusion, quantum computing and developing treatments and cures for infectious diseases. Founded in 2015, we’ve raised over £600M to create a world-class technology ecosystem, and combine our deep experience with a network of investors, entrepreneurs and sector-experts to find co-investment, build businesses, and hire senior management talent.

## UK Innovation & Science Seed Fund
- Type: VC Fund
- Location: Harwell, Oxfordshire, United Kingdom
- Relevant deals: 13
- Stages: Seed, Series A
- Focus: Biotechnology, Health Care, Medical

UKI2S, formally the Rainbow Seed Fund, is an investment fund backed by the government, providing seed funding to science & technology start-ups and SMEs

## RA Capital Management
- Type: VC Fund
- Location: Boston, Massachusetts, United States
- Relevant deals: 13
- Stages: Series B, Series A, Series C
- Focus: Biotechnology, Health Care, Therapeutics

RA Capital Management is an investment advisor based in Boston specializing in the life-sciences and drug development sectors. Their team has been investing since 2002 and is comprised of professionals with training in biology, chemistry, and medicine and also has industry and business development experience at the executive and board levels. Theyinvest in companies with promising technologies and products. Their approach is to achieve a superior understanding of data, experimental/trial design, regulatory process, and commercial potential. When appropriate, they can offer their portfolio companies leads on in-licensing opportunities and strategic partnerships, as well as insight into the demands of the public markets.

## Versant Ventures
- Type: VC Fund
- Location: Menlo Park, California, United States
- Relevant deals: 12
- Stages: Series A, Series B, Series C
- Focus: Biotechnology, Health Care, Medical

Versant partners with exceptional entrepreneurs to build and fund breakthrough biotechnology companies around the globe.

## Google Ventures
- Type: VC Fund
- Location: Mountain View, California, United States
- Relevant deals: 12
- Stages: Series B, Series A, Seed
- Focus: Software, Health Care, Biotechnology

GV supports innovative founders moving the world forward.

## Roche Venture Fund
- Type: VC Fund
- Location: Basel, Basel-Stadt, Switzerland
- Relevant deals: 11
- Stages: Series B, Series A, Series C
- Focus: Biotechnology, Health Care, Therapeutics

The Roche Venture Fund is the name given to the corporate venture fund of the healthcare company Roche. Roche has allocated CHF 500 million to invest in and develop commercially successful innovative life science companies. Roche has been investing in early stage companies as part of collaborations since the early-1990s and independent ofcollaborations since 2002. All equity investments made by Roche in biotech and diagnostics companies (including collaboration investments) are negotiated and managed by the Roche Venture Fund. In the past 20 years, the Roche Venture Fund has invested in over 60 companies globally. Currently, Roche Venture Fund has a portfolio of around 30 companies located in 10 countries across Europe, North America and the Pacific Region. The fund is an evergreen fund with CHF 500 million available of which approximately 40% is currently invested.The Roche Venture Fund is a committed long-term stable investor with sufficient money reserved in their fund for follow-on financing rounds. As part of a multinational healthcare company, the Roche Venture Fund has access to considerable expertise both internally and externally. We co-invest with leading venture funds, including other corporate venture funds, on a regular basis.

## 5AM Ventures
- Type: VC Fund
- Location: Menlo Park, California, United States
- Relevant deals: 11
- Stages: Series A, Series B, Series C
- Focus: Biotechnology, Health Care, Therapeutics

5AM Ventures is a venture capital firm that offers seed- and early-stage investments to its clients. The company’s client portfolio consists of firms in the biopharmaceutical, life sciences, medical technology, and research instrument industries.
5AM Ventures was founded in 2002 by John Diekman and Andrew Schwab and is based in California.

## 8VC
- Type: VC Fund
- Location: San Francisco, California, United States
- Relevant deals: 11
- Stages: Seed, Series A, Series B
- Focus: Software, Health Care, Information Technology

8VC seeks to enable industry transformation. In a wave of creative destruction, they believe emerging platforms will replace the decades-old technology infrastructure behind many industries, promoting greater innovation and prosperity.

## Horizons Ventures
- Type: VC Fund
- Location: Hong Kong, Hong Kong Island, Hong Kong
- Relevant deals: 11
- Stages: Series A, Series B, Seed
- Focus: Biotechnology, Artificial Intelligence, Software

Investing in the deep science and technology that can propel humanity towards a radically better future.

## Atlas Venture
- Type: VC Fund
- Location: Cambridge, Massachusetts, United States
- Relevant deals: 11
- Stages: Series A, Series B, Series C
- Focus: Biotechnology, Health Care, Therapeutics

Atlas Venture is an early-stage venture capital firm that creates and invests in biotech startup companies led by promising entrepreneurs focusing on life sciences innovation. Its seed-led venture creation strategy rigorously selects and focuses investment on the most compelling opportunities to build scalable businesses and realize value.

## MPM Capital
- Type: VC Fund
- Location: Cambridge, Massachusetts, United States
- Relevant deals: 11
- Stages: Series B, Series A, Series C
- Focus: Biotechnology, Health Care, Pharmaceutical

Powering Breakthroughs in Life Sciences

## Third Rock Ventures
- Type: VC Fund
- Location: Boston, Massachusetts, United States
- Relevant deals: 10
- Stages: Series A, Series B, Series C
- Focus: Biotechnology, Health Care, Therapeutics

Third Rock Ventures is a leading healthcare venture firm focused on advancing disruptive areas of science and medicine to deliver breakthroughs to patients.

## Takeda Ventures
- Type: VC Fund
- Location: San Diego, California, United States
- Relevant deals: 10
- Stages: Series A, Series B
- Focus: Biotechnology, Health Care, Therapeutics

Takeda Ventures, Inc. (TVI) is the corporate investment arm of Takeda Pharmaceutical Company Limited (TPC). TVI was founded in 2001 and invests in current and future areas of interest for TPC. They are based alongside Takeda’s R&D sites in Cambridge, MA, and San Diego, CA. As a strategic investor, TVI aims to provide support and guidance toentrepreneurs and early-stage companies driving concepts through clinical proof of concept. They also strive to forge active, collaborative interactions that result in synergies with Takeda's considerable R&D resources. Their goal is to build a portfolio of strategic investments, with an immediate emphasis on oncology, gastroenterology, neuroscience, and rare diseases.

## KdT Ventures
- Type: VC Fund
- Location: Austin, Texas, United States
- Relevant deals: 10
- Stages: Seed, Series A, Series B
- Focus: Biotechnology, Health Care, Medical

KdT Ventures is the standard for early-stage frontier science investing.

## Kurma Partners
- Type: VC Fund
- Location: Paris, Ile-de-France, France
- Relevant deals: 10
- Stages: Series A, Seed, Series B
- Focus: Health Care, Biotechnology, Medical

Kurma Partners is a management company based in Paris, specializing in the financing of innovation in healthcare and biotechnology, from pre-creation to development capital. Kurma Partners, which manages the Kurma Biofund I, II funds and the Kurma Diagnostics fund, is one of the main players in the financing of therapeutic and medical innovationsin Europe, particularly through links with many institutes. research and prestigious hospitals.

## Hatteras Venture Partners
- Type: VC Fund
- Location: Durham, North Carolina, United States
- Relevant deals: 10
- Stages: Series A, Series B
- Focus: Biotechnology, Health Care, Medical

Hatteras Venture Partners is a venture capital firm based in Research Triangle Park, NC, with a focus on biopharmaceuticals, medical devices, diagnostics, and related opportunities in human medicine. Founded in 2000, the firm consists of an experienced team with a broad and complementary skill set that is particularly relevant to buildingsuccessful new biomedical companies. The Hatteras Venture Partners team brings operational experience, a successful track record, and a proven ability to enhance the value of the companies in which it invests. With three funds, the firm has more than $120 million under management.

## Dementia Discovery Fund
- Type: VC Fund
- Location: London, England, United Kingdom
- Relevant deals: 10
- Stages: Seed, Series A
- Focus: Biotechnology, Health Care, Therapeutics

SV Health Investors is a specialist healthcare fund manager, investing across multiple stages and sectors. Our goal is to transform healthcare one investment at a time.

## M Ventures
- Type: VC Fund
- Location: Amsterdam, Noord-Holland, The Netherlands
- Relevant deals: 10
- Stages: Series A, Series B, Seed
- Focus: Biotechnology, Health Care, Therapeutics

Merck Ventures is the strategic, corporate venture capital arm of Merck. Its mandate is to invest in innovative technologies and products with the potential to significantly impact Merck‘s core business areas. From its headquarters in Amsterdam and offices in the US and Israel we invest globally in transformational ideas driven by greatentrepreneurs. Merck Ventures takes an active role in its portfolio companies and teams up with entrepreneurs and co-investors to translate innovation towards commercial success. Merck Ventures has a significant focus on early-stage investing and company creation including the creation of spin-offs to leverage Merck‘s science and technology base.

## DCVC
- Type: VC Fund
- Location: San Francisco, California, United States
- Relevant deals: 10
- Stages: Seed, Series A, Series B
- Focus: Software, Artificial Intelligence, Health Care

We are deep tech venture capital.

## Sahsen Ventures
- Type: VC Fund
- Location: Seattle, Washington, United States
- Relevant deals: 9
- Stages: Series A, Seed
- Focus: Biotechnology, Health Care, Non Profit

Sahsen Ventures is a venture capital firm making investments in for-profit and nonprofit organizations with an emphasis on technology and biotechnology. It was established in 2016 and is based in Seattle, Washington.

## Rev1 Ventures
- Type: VC Fund
- Location: Columbus, Ohio, United States
- Relevant deals: 9
- Stages: Seed, Series A
- Focus: Software, Health Care, Information Technology

Rev1 Ventures provides seed stage venture capital funding in Columbus, Ohio along with startup services, space, mentoring, and connections. Learn more!

## Casdin Capital
- Type: VC Fund
- Location: New York, New York, United States
- Relevant deals: 9
- Stages: Series B, Series A, Series C
- Focus: Biotechnology, Health Care, Therapeutics

Casdin Capital is a fundamental research investment firm focused on the life sciences and healthcare industry. It manages a long-short equity fund and makes investments in early-stage to late-stage private investments. Casdin was launched in 2012 by founder and CIO Eli Casdin and as of October 2020 has approximately $2.2 billion in assets undermanagement.

## Vivo Capital
- Type: VC Fund
- Location: Palo Alto, California, United States
- Relevant deals: 9
- Stages: Series B, Series A, Series C
- Focus: Biotechnology, Health Care, Pharmaceutical

Vivo Capital is a healthcare focused investment firm formed in 1996 that is currently making investments from its $1.4B Vivo Capital Fund IX into promising private healthcare companies and from its $635M Vivo Opportunity Fund into promising public healthcare companies.

## Lux Capital
- Type: VC Fund
- Location: New York, New York, United States
- Relevant deals: 9
- Stages: Series A, Seed, Series B
- Focus: Software, Health Care, Biotechnology

Lux Capital manages over $5 billion in assets focused on founding, seed, early-stage, and growth investments at the intersection of technology and the sciences. Lux takes an active role in helping entrepreneurs build successful businesses in high growth sectors. Its investment team has built over 20 companies from scratch. Lux's investmentstrategy ensures our portfolio companies are better connected, have a deeper insight, and command industry leadership faster than their competitors.

## Alix Ventures
- Type: VC Fund
- Location: San Francisco, California, United States
- Relevant deals: 9
- Stages: Seed, Series A, Pre-Seed
- Focus: Biotechnology, Health Care, Life Science

Supporting early stage Life Science startups driving patient impact. Born from our collective experience as founders, we set out to build the fund we wanted to raise from....

## Civilization Ventures
- Type: VC Fund
- Location: San Francisco, California, United States
- Relevant deals: 9
- Stages: Seed, Series A, Series B
- Focus: Biotechnology, Health Care, Medical

DIGITAL HEALTH / AI     
DIGITAL HEALTH / AI     GENE / CELL THERAPIES
NASDAQ: RCKT      GENE / CELL THERAPIES
NASDAQ: RCKT      GENOMICS / DIAGNOSTICS     GENOMICS / DIAGNOSTICS     
SYNTHETIC

## Andreessen Horowitz
- Type: VC Fund
- Location: Menlo Park, California, United States
- Relevant deals: 9
- Stages: Series A, Series B, Seed
- Focus: Software, Information Technology, Internet

Andreessen Horowitz (a16z) is a venture capital firm in Silicon Valley, California, investing in bold founders, innovators, and entrepreneurs building the future through technology.

## JDRF T1D Fund
- Type: VC Fund
- Location: Boston, Massachusetts, United States
- Relevant deals: 9
- Stages: Series A, Series B
- Focus: Biotechnology, Health Care, Medical

The JDRF T1D Fund (www.t1dfund.org) is a venture philanthropy fund exclusively devoted to finding and funding the best early-stage T1D commercial opportunities to accelerate the delivery of treatments, preventions, and cures to patients. It was created to solve a critical funding gap in the T1D drug and device development pipeline. Throughpartnerships with private capital, including venture capital, pharma and foundations, the T1D Fund anticipates that it will be able to attract substantially more private investment to the T1D field than occurs today. The T1D Fund will initially focus on artificial pancreas systems, metabolic control, beta cell replacement, prevention, and beta cell restoration therapies, with an exclusive priority on the best commercial opportunities. The T1D Fund will reinvest any realized gains into new investments to further its mission.

## New Enterprise Associates
- Type: VC Fund
- Location: Menlo Park, California, United States
- Relevant deals: 9
- Stages: Series B, Series A, Series C
- Focus: Software, Health Care, Biotechnology

New Enterprise Associates, Inc. is a global venture capital firm focused on helping entrepreneurs build transformational businesses across multiple stages, sectors, and geographies. With over $19 billion in cumulative committed capital since the firm’s founding in 1977, NEA invests in technology and healthcare companies at all stages in a company’slifecycle, from seed stage through IPO. The firm's long track record of successful investing includes more than 210 portfolio company IPOs and more than 360 acquisitions.

## Seventure Partners
- Type: VC Fund
- Location: Paris, Ile-de-France, France
- Relevant deals: 8
- Stages: Series A, Series B
- Focus: Biotechnology, Health Care, Software

Seventure Partners is a French venture capital firm targeting in information and communication technology, and life sciences companies. It funds innovation and participates in the entrepreneurial adventure, alongside entrepreneurs and sharing their passion.Founded in 1997, Seventure Partners is one of the European leaders in venture capital, with€ 660 million under management as of December 31, 2016. It is an active partner of innovative companies that, according to the management team, show strong growth potential and evolving in two fields of activity: Digital Technologies and Life Sciences. With more than 20 employees, including some 15 investors, Seventure Partners has a proven track record and in-depth expertise in technology, entrepreneurship, and various private equity operations.Seventure's goal is to identify and support the development of tomorrow's European leaders in order to accelerate their growth. To do this, the firm provides entrepreneurs with the expertise, networks, and know-how of its internal team of investors.

## Longwood Fund
- Type: VC Fund
- Location: Boston, Massachusetts, United States
- Relevant deals: 8
- Stages: Series A, Series B, Series C
- Focus: Biotechnology, Health Care, Therapeutics

Longwood creates and invests in science-based companies that develop novel solutions for important medical problems

## Omega Funds
- Type: VC Fund
- Location: Boston, Massachusetts, United States
- Relevant deals: 8
- Stages: Series B, Series A, Series C
- Focus: Biotechnology, Health Care, Therapeutics

We aim to invest in exceptional founders and entrepreneurs and impactful products and platforms across multiple therapeutic areas.

## High-Tech Grunderfonds
- Type: VC Fund
- Location: Bonn, Nordrhein-Westfalen, Germany
- Relevant deals: 8
- Stages: Seed, Series A
- Focus: Software, Information Technology, Biotechnology

High-Tech Gründerfonds (HTGF) is a seed investor that finances high-potential, tech-driven startups. With EUR 895.5 million in total investment volume across three funds and an international network of partners, HTGF has already helped forge more than 500 startups since 2005. Driven by their expertise, entrepreneurial spirit, and passion, its teamof experienced investment managers and startup experts help guide the development of young companies. HTGF’s focus is on high-tech startups in a range of sectors, including software, media, internet, hardware, automation, health care, chemistry, and life sciences.To date, external investors have injected over EUR 2 billion into the HTGF portfolio via about 1,400 follow-on financing rounds. HTGF has also successfully sold interests in more than 100 companies. Investors in this public-private partnership include the Federal Ministry For Economic Affairs and Energy, the KfW Banking Group, and Fraunhofer-Gesellschaft e.V., as well as the companies ALTANA, BASF, BAYER, B.Braun, Boehringer Ingelheim, Robert Bosch, BÜFA, CEWE, Deutsche Post DHL, Dräger, Drillisch AG, EVONIK, EWE AG, FOND OF Haniel, Hettich, Knauf, Körber, LANXESS, media + more venture Beteiligungs GmbH & Co. KG, PHOENIX CONTACT, Postbank, QIAGEN, RWE Generation SE, SAP, Schufa, Schwarz Gruppe, STIHL, Thüga, Vector Informatik, WACKER and Wilh. Werhahn KG.

## Advent Life Sciences
- Type: VC Fund
- Location: London, England, United Kingdom
- Relevant deals: 8
- Stages: Series A, Series B
- Focus: Biotechnology, Health Care, Medical

Advent Life Sciences is a venture team investing in life sciences businesses. The team consists of 11 professionals with extensive scientific, medical and operational experience, and a long-standing track record of entrepreneurial and investment success across the UK, Europe and the US. The Firm invests in a range of sectors within life sciences,principally in new drug discovery, enabling technologies, and med tech. Realizations in the last three years include Algeta, Avila, CN Creative, EUSA, Micromet. Current investments include Acutus, Biocartis, Cellnovo, f2G, NeRRe,

## AbbVie Biotech Ventures
- Type: VC Fund
- Location: North Chicago, Illinois, United States
- Relevant deals: 8
- Stages: Series A, Series B, Series C
- Focus: Biotechnology, Health Care, Therapeutics

AbbVie is a global, research-based biopharmaceutical company formed in 2013 following separation from Abbott Laboratories. The company's mission is to use its expertise, dedicated people and unique approach to innovation to develop and market advanced therapies that address some of the world's most complex and serious diseases. Togetherwith its wholly-owned subsidiary, Pharmacyclics, AbbVie employs ~29,000 people worldwide and markets medicines in more than 175 countries.

## Archangels
- Type: VC Fund
- Location: Edinburgh, Edinburgh, City of, United Kingdom
- Relevant deals: 8
- Stages: Seed, Series A
- Focus: Software, Biotechnology, Health Care

Established in 1992. Archangels is the oldest continuously operating business angel syndicate in the World. Investing in IP-rich tech & life sciences companies in Scotland, UK.

## Enterprise Ireland
- Type: VC Fund
- Location: Dublin, Dublin, Ireland
- Relevant deals: 8
- Stages: Seed, Series A
- Focus: Software, Health Care, Information Technology

Enterprise Ireland is the government agency responsible for the development and funding of the indigenous business sector. Their mission is to accelerate the development of companies to achieve strong positions in global markets resulting in increased national and regional prosperity.
It was founded in 1998 and headquartered in Dublin, Ireland.

## iSelect Fund
- Type: VC Fund
- Location: St Louis, Missouri, United States
- Relevant deals: 8
- Stages: Seed, Series A, Series B
- Focus: Biotechnology, Health Care, Agriculture

Venture investing in Food, Health, and AgTech. A generational investment thesis. Food is Health is longevity

## Jonathan Milner
- Type: Angel
- Location: Cambridge, Massachusetts, United States
- Relevant deals: 8
- Stages: Seed, Series A, Series B
- Focus: Biotechnology, Health Care, Medical

Having worked in the life sciences industry for over ten years as an academic researcher, Jonathan identified the market opportunity for supplying high quality antibodies to support protein interaction studies and, in 1998, founded Abcam with David Cleevely and Professor Tony Kouzarides. Jonathan is a Non-Executive Director of Horizon DiscoveryGroup plc, The Evolution Education Trust, GeoSpock Ltd and Sydicate Room Group Ltd. He is also Chairman of Axol Bioscience Ltd, PhoreMost Ltd, Repositive Limited, Definigen Limited and Cambridge Allergy Ltd. Jonathan holds an executive director position at Meltwind Limited, being a designated member of Meltwind Advisory LLP. Jonathan is an experienced entrepreneur and investor and is passionate about supporting UK life science and high-tech start-ups. He has provided considerable investment and support to over 30 companies and has assisted three AIM IPOs.

## Bpifrance
- Type: VC Fund
- Location: Maisons-alfort, Ile-de-France, France
- Relevant deals: 8
- Stages: Seed, Series A
- Focus: Software, Health Care, Information Technology

Bpifrance provides financial solutions for companies that are booting up the listing on the stock exchange and credit equity. It includes OSEO, CDC Entreprises, FSI, and FSI Regions to offer in your area of financial solutions at every stage of the life of your business.Bpifrance was founded in 2012 and is based in Maisons-alfort, Ile-de-France,France.

## Breakout Ventures
- Type: VC Fund
- Location: San Francisco, California, United States
- Relevant deals: 8
- Stages: Series B, Seed, Series A
- Focus: Biotechnology, Life Science, Therapeutics

Breakout Ventures is a new, early stage fund that backs bold scientist entrepreneurs working at the intersections of technology, biology, materials, and energy.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co